Total submissions: 22
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000162570 | SCV000212986 | benign | Hereditary cancer-predisposing syndrome | 2014-12-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000174706 | SCV000226060 | benign | not specified | 2014-08-21 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000174706 | SCV000539813 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Silent, high frequency |
Invitae | RCV001083142 | SCV000557584 | benign | Familial adenomatous polyposis 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000162570 | SCV000685576 | benign | Hereditary cancer-predisposing syndrome | 2016-03-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000174706 | SCV000806343 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000174706 | SCV000889520 | benign | not specified | 2020-08-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000759880 | SCV001159237 | benign | not provided | 2023-04-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000759880 | SCV001248076 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | MUTYH: BP4, BP7, BS1, BS2 |
Illumina Laboratory Services, |
RCV001083142 | SCV001253573 | likely benign | Familial adenomatous polyposis 2 | 2018-02-09 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000759880 | SCV001836968 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27829682, 27884173, 16774938, 20981092) |
Sema4, |
RCV000162570 | SCV002532237 | benign | Hereditary cancer-predisposing syndrome | 2020-08-18 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000174706 | SCV002547277 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498804 | SCV002795890 | benign | Familial adenomatous polyposis 2; Gastric cancer | 2022-03-17 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000162570 | SCV004014952 | benign | Hereditary cancer-predisposing syndrome | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001353747 | SCV000592717 | uncertain significance | Carcinoma of colon | no assertion criteria provided | clinical testing | The p.Thr477Thr (c.1431G>C ) variant (alias 1389G>C) has been previously reported in the literature in 14/332 proband chromosomes (frequency 0.048) in individuals affected with either adenomatous polyposis, gastric cancer or colorectal cancer, however controls were not included in these studies (Peterlongo 2006, Tao 2004, Yanaru-Fujisawa 2008). This variant has also been identified in the HGMD and LOVD databases, however it is not expected to have clinical significance because it does not alter an amino acid residue, is not located near a splice junction, and has been reported in dbSNP (ID#:rs74318065), by the 1000 genomes project (frequency 0.016), and ESP project (frequency 0.004). However, there is some conflicting information in the literature. In one study the variant c.1431G > C was found to be in complete linkage disequilibrium with two other MUTYH variants, –280G > A and c.36+11C>T (alias IVS1+11C>T). A statistically significant association was demonstrated between one of these variants, c.36+11C>T and increased CRC risk (Tao 2008). This indicates that individuals with the MUTYH – 280A/c.36+11T/c.1431C genotypes may be susceptible to CRC (Tao 2008). However, replication in additional cohorts and additional functional evidence would be required to validate this finding. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. Therefore, this variant is classified as a variant of unknown significance (VUS). | |
True Health Diagnostics | RCV000162570 | SCV000788064 | likely benign | Hereditary cancer-predisposing syndrome | 2017-06-21 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000759880 | SCV001800318 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000174706 | SCV001807696 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000759880 | SCV001921567 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000759880 | SCV001960022 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000174706 | SCV001964337 | benign | not specified | no assertion criteria provided | clinical testing |